Search research articles
Contact Us
Filters
Showing results (21-30 of 48) with videos related to
Page
of 5
Sort By:
Cancer Genetics
|
November 26, 2016
Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients
Qing Liu, Luke B Hesson, Andrea C Nunez, et al.
JAMA Oncology
|
July 17, 2015
Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal Cancer
Mathew A Sloane, Andrea C Nunez, Deborah Packham, et al.
Current Biology : CB
|
June 30, 2009
RAN GTPase is a RASSF1A effector involved in controlling microtubule organization
Ashraf Dallol, Luke B Hesson, David Matallanas, et al.
Plos Genetics
|
August 13, 2013
Reassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposure
Luke B Hesson, Vibha Patil, Mathew A Sloane, et al.
BMC Cancer
|
July 22, 2016
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Sean S Q Ma, Sameer Srivastava, Estelle Llamosas, et al.
European Journal of Gastroenterology & Hepatology
|
January 29, 2013
A correlation of the endoscopic characteristics of colonic laterally spreading tumours with genetic alterations
Andrew J Metz, Michael J Bourke, Alan Moss, et al.
Asian Journal of Andrology
|
November 27, 2015
Obesity-induced sperm DNA methylation changes at satellite repeats are reprogrammed in rat offspring
Neil A Youngson, Virginie Lecomte, Christopher A Maloney, et al.
The Journal of Biological Chemistry
|
December 14, 2005
The RASSF1A tumor suppressor activates Bax via MOAP-1
Michele D Vos, Ashraf Dallol, Kristin Eckfeld, et al.
Epigenetics
|
December 2, 2014
Altered promoter nucleosome positioning is an early event in gene silencing
Luke B Hesson, Mathew A Sloane, Jason Wh Wong, et al.
Virchows Archiv : an International Journal of Pathology
|
September 16, 2016
Validation of specificity of antibodies for immunohistochemistry: the case of ROR2
Sean S Q Ma, Claire E Henry, Estelle Llamosas, et al.
Page
of 5
Search research articles
Search
Showing results (21-30 of 48) with videos related to
Sort By:
Page
of 5
Cancer Genetics
|
November 26, 2016
Pathogenic germline MCM9 variants are rare in Australian Lynch-like syndrome patients
Qing Liu, Luke B Hesson, Andrea C Nunez, et al.
JAMA Oncology
|
July 17, 2015
Mosaic Epigenetic Inheritance as a Cause of Early-Onset Colorectal Cancer
Mathew A Sloane, Andrea C Nunez, Deborah Packham, et al.
Current Biology : CB
|
June 30, 2009
RAN GTPase is a RASSF1A effector involved in controlling microtubule organization
Ashraf Dallol, Luke B Hesson, David Matallanas, et al.
Plos Genetics
|
August 13, 2013
Reassembly of nucleosomes at the MLH1 promoter initiates resilencing following decitabine exposure
Luke B Hesson, Vibha Patil, Mathew A Sloane, et al.
BMC Cancer
|
July 22, 2016
ROR2 is epigenetically inactivated in the early stages of colorectal neoplasia and is associated with proliferation and migration
Sean S Q Ma, Sameer Srivastava, Estelle Llamosas, et al.
European Journal of Gastroenterology & Hepatology
|
January 29, 2013
A correlation of the endoscopic characteristics of colonic laterally spreading tumours with genetic alterations
Andrew J Metz, Michael J Bourke, Alan Moss, et al.
Asian Journal of Andrology
|
November 27, 2015
Obesity-induced sperm DNA methylation changes at satellite repeats are reprogrammed in rat offspring
Neil A Youngson, Virginie Lecomte, Christopher A Maloney, et al.
The Journal of Biological Chemistry
|
December 14, 2005
The RASSF1A tumor suppressor activates Bax via MOAP-1
Michele D Vos, Ashraf Dallol, Kristin Eckfeld, et al.
Epigenetics
|
December 2, 2014
Altered promoter nucleosome positioning is an early event in gene silencing
Luke B Hesson, Mathew A Sloane, Jason Wh Wong, et al.
Virchows Archiv : an International Journal of Pathology
|
September 16, 2016
Validation of specificity of antibodies for immunohistochemistry: the case of ROR2
Sean S Q Ma, Claire E Henry, Estelle Llamosas, et al.
Page
of 5